» Articles » PMID: 34975894

Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis

Overview
Journal Front Immunol
Date 2022 Jan 3
PMID 34975894
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is an autoimmune disease that leads to the demyelination of nerve axons. An increasing number of studies suggest that patients with MS exhibit altered metabolic profiles, which might contribute to the course of MS. However, the alteration of metabolic profiles in Chinese patients with MS and their potential roles in regulating the immune system remain elusive. In this study, we performed a global untargeted metabolomics approach in plasma samples from 22 MS-affected Chinese patients and 21 healthy subjects. A total of 42 differentially abundant metabolites (DAMs) belonging to amino acids, lipids, and carbohydrates were identified in the plasma of MS patients and compared with those in healthy controls. We observed an evident reduction in the levels of amino acids, such as L-tyrosine, L-isoleucine, and L-tryptophan, whereas there was a great increase in the levels of L-glutamic acid and L-valine in MS-affected patients. The levels of lipid and carbohydrate metabolites, such as sphingosine 1-phosphate and myo-inositol, were also reduced in patients with MS. In addition, the concentrations of proinflammatory cytokines, such as IL-17 and TNF-α, were significantly increased, whereas those of several anti-inflammatory cytokines and chemokines, such as IL-1ra, IL-7, and MIP-1α, were distinctly reduced in the plasma of MS patients compared with those in healthy subjects. Interestingly, some DAMs, such as L-tryptophan and sphingosine 1-phosphate, showed an evident negative correlation with changes in the level of TNF-α and IL-17, while tightly positively correlating with altered concentrations of anti-inflammatory cytokines and chemokines, such as MIP-1α and RANTES. Our results revealed that altered metabolomic profiles might contribute to the pathogenesis and course of MS disease by modulating immuno-inflammatory responses in the peripheral system, which is essential for eliciting autoimmune responses in the central nervous system, thus resulting in the progression of MS. This study provides potential clues for developing therapeutic strategies for MS in the near future.

Citing Articles

Transcriptomic profiling identifies ferroptosis and NF-κB signaling involved in α-dimorphecolic acid regulation of microglial inflammation.

Zhu X, Wang P, Chao S, Tang W, Zhao L, Yu L J Transl Med. 2025; 23(1):260.

PMID: 40038710 PMC: 11877847. DOI: 10.1186/s12967-025-06296-7.


Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosis.

Yang F, Zhao L, Yang W, Chao S, Ling Z, Sun B BMC Neurol. 2024; 24(1):423.

PMID: 39478468 PMC: 11526627. DOI: 10.1186/s12883-024-03926-3.


Chuanxiong Renshen Decoction Inhibits Alzheimer's Disease Neuroinflammation by Regulating PPARγ/NF-κB Pathway.

Hou J, Wang X, Zhang J, Shen Z, Li X, Yang Y Drug Des Devel Ther. 2024; 18:3209-3232.

PMID: 39071817 PMC: 11283787. DOI: 10.2147/DDDT.S462266.


Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.

Montgomery T, Peipert D, Krementsov D Immunol Rev. 2024; 325(1):131-151.

PMID: 38717158 PMC: 11338732. DOI: 10.1111/imr.13343.


Myeloid cell-associated aromatic amino acid metabolism facilitates CNS myelin regeneration.

Hu J, Melchor G, Ladakis D, Reger J, Kim H, Chamberlain K NPJ Regen Med. 2024; 9(1):1.

PMID: 38167866 PMC: 10762216. DOI: 10.1038/s41536-023-00345-9.


References
1.
Senanayake V, Jin W, Mochizuki A, Chitou B, Goodenowe D . Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study. BMC Neurol. 2015; 15:154. PMC: 4549881. DOI: 10.1186/s12883-015-0411-4. View

2.
Obert D, Helms G, Sattler M, Jung K, Kretzschmar B, Bahr M . Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study. PLoS One. 2016; 11(9):e0162583. PMC: 5026363. DOI: 10.1371/journal.pone.0162583. View

3.
Rao G, Sui J, Zhang J . Metabolomics reveals significant variations in metabolites and correlations regarding the maturation of walnuts (Juglans regia L.). Biol Open. 2016; 5(6):829-36. PMC: 4920193. DOI: 10.1242/bio.017863. View

4.
Berer K, Mues M, Koutrolos M, Al Rasbi Z, Boziki M, Johner C . Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011; 479(7374):538-41. DOI: 10.1038/nature10554. View

5.
Keller J, Zackowski K, Kim S, Chidobem I, Smith M, Farhadi F . Exercise leads to metabolic changes associated with improved strength and fatigue in people with MS. Ann Clin Transl Neurol. 2021; 8(6):1308-1317. PMC: 8164856. DOI: 10.1002/acn3.51368. View